J038-0630 Screening compound: 9-methyl-5-[4-(prop-2-yn-1-yloxy)phenyl]-2H,3H,4H,4aH,5H,6H,10bH-pyrano[3,2-c]quinoline

J038-0630 Screening compound: 9-methyl-5-[4-(prop-2-yn-1-yloxy)phenyl]-2H,3H,4H,4aH,5H,6H,10bH-pyrano[3,2-c]quinoline
J038-0630 Screening compound: 9-methyl-5-[4-(prop-2-yn-1-yloxy)phenyl]-2H,3H,4H,4aH,5H,6H,10bH-pyrano[3,2-c]quinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound J038-0630
9-methyl-5-[4-(prop-2-yn-1-yloxy)phenyl]-2H,3H,4H,4aH,5H,6H,10bH-pyrano[3,2-c]quinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J038-0630

Molecular Formula

C22H23NO2 (C22 H23 NO2)

Compound Name

9-methyl-5-[4-(prop-2-yn-1-yloxy)phenyl]-2H,3H,4H,4aH,5H,6H,10bH-pyrano[3,2-c]quinoline

IUPAC name

(4aS10bS)-9-methyl-5-[4-(prop-2-yn-1-yloxy)phenyl]-2H3H4H4aH5H6H10bH-pyrano[32-c]quinoline

SMILES

Cc(cc1)cc([C@H]2OCCC[C@H]22)c1NC2c(cc1)ccc1OCC#C

InChI

InChI=1S/C22H23NO2/c1-3-12-24-17-9-7-16(8-10-17)21-18-5-4-13-25-22(18)19-14-15(2)6-11-20(19)23-21/h1,6-11,14,18,21-23H,4-5,12-13H2,2H3/t18-,21?,22-/m0/s1

InChI Key

ZCSVJYWBZRLXFL-HURFNXGFSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

333.43

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

4.219

Distribution Coefficient, logD

4.219

Water Solubility, LogSw

-4.27

Polar Surface Area

28.248

Acid Dissociation Constant (pKa)

19.64

Base Dissociation Constant (pKb)

4.90

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

36.40

J038-0630 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
  • Cyclic compounds
  • 3D
  • Fragments
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with J038-0630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J038-0630?
Check Price and Availability of J038-0630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J038-0630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J038-0630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J038-0630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J038-0630 available by request